Pfizer's $400M Class Action Settlement Gets Early Nod
A New York federal judge on Monday granted early approval to a $400 million settlement ending a class action lawsuit accusing Pfizer Inc. of misleading investors about illegal off-label drug marketing,...To view the full article, register now.
Already a subscriber? Click here to view full article